A brief review is given on the value of neopterin determination as a biochemical marker for the in vivo activation state of cell-mediated immunity. In a broad spectrum of diseases which are recognized or supposed to involve activation of monocytes/macrophages by interferon gamma derived from activated T lymphocytes, the applicability and utility of this technically simple test for a variety of specific clinical questions have been demonstrated by a multitude of authors. Applications are e. g. early detection of immunological complications in recipients of allografts, monitoring of inflammatory flare-up in patients with autoimmune disorders, the management of patients with malignant tumours and the monitoring of the clinical course in individuals with various infections and particularly with the human immunodeficiency virus. By measuring levels of neopterin in body fluids , information on the actual state of cell~mediated immunity in vivo is obtained that is not easily achieved by other techniques.
Introduction
Three clinical conditions are known which lead to raised neopterin levels: 1. conditions involving activation of cell-mediated immunity, 2. impaired renal function, which causes raised serum levels but normal ratios of neopterin to creatinine are found in serum and in urine, 3. a certain variant of atypical phenylketonuria which is caused by dihydrobiopterin synthase deficiency and which has an extremely low incidence.
Neopterin levels are easily detected by high performance liquid chromatography (HPLC) in urine and in serum or by radioimmunoassay (RIA) in serum. For clinical purposes, measurement of neat, i. e. the aromatic, neopterin should be preferred rather than detection of reduced neopterin species or total neopterin, since no pretreatment of specimens is required, and the stability of the aromatic neopterin facilitates handling of specimens considerably.
This review deals with the application of the neopterin test as an in vivo marker for the activation of cellmediated immunity which correlates with in vitro experiments having demonstrated the dependence of neopterin release by monocytes/macrophages on the induction of these cells by interferon-gamma (1, 2) . High neopterin levels are a sensitive indicator of conditions involving activation of cellular immunity but are not specific for a certain disease. Among the diseases investigated hitherto with respect to the behaviour of neopterin levels are immunological complications such as graft rejections or infections in transplant recipients, infections with viruses, with intracellular bacteria or with parasites, autoimmune conditions and, finally, malignant diseases.
Allograft Rejections
The utility of neopterin for early assessment of clinical complications of allograft recipients such as rejection and infection episodes was studied by several authors (3 -9) . It can be concluded from these reports that allograft rejections and infections can be sensitively detected by rising neopterin levels when measured daily. Importantly, clinically uncomplicated posttransplant courses are characterized by stable and low neopterin levels.
Serum levels of interferon-gamma and of neopterin were concomitantly determined during the posttransplant course (8, 9) . Distinct increases of neopterin levels accompanied both rejections and infections. In contrast, raised levels of interferon-gamma were seen during periods of severe infections but not or only rarely during rejections. This was tentatively explained by the more locally restricted production of interferon-gamma in rejection and the restricted ability of this protein molecule to enter the circulation via diffusion, in contrast to the small molecule neopterin (8, 9) .
The clinical value of neopterin levels was found to be superior to that of ~rmicroglobulin for assessment of complications in renal allograft recipients (4) . The application of urinary neopterin levels for diagnosis and prognosis of cytomegalovirus infection in recipients of allografts was studied (6) . Neopterin levels increased more than one week earlier than antibody titers. The levels of neopterin were indicative for the severity of infection, and they started to decline with the appearance of anti-CMV antibodies and with the resolution of infection.
A similar correlation between serial urinary neopterin levels and clinical course was observed on bone marrow transplant recipients by several laboratories (10) (11) (12) . The excretion of neopterin was minimal during bone marrow aplasia. Engraftment was preceded by rising neopterin levels. Graft versus host disease and infections were indicated by rise of neopterin levels that preceded the clinical manifestations by several days.
Infectious Diseases

Viral infections
Raised neopterin levels were described in urine specimens of patients with viral infections already in the first publication in 1979 reporting on the increased neopterin excretion in various clinical conditions (13) . The increase and subsequent decrease of neopterin levels during the course of viral infections is of particular interest. As example, serial urinary neopterin levels were determined in 4 children with chickenpox infection (14) . Neopterin levels began to rise dramatically 1 to 2 days before the typical exanthema appeared. Subsequent to a sharp peak, neopterin levels decreased rapidly coincident with the period when specific antibodies became measurable.
A similar course of daily measured neopterin levels correlating with clinical symptoms was observed in 18 patients with rubella, in 12 with chickenpox, and in 15 with influenza (15 In patients with virus-induced hepatitis, several studies were performed (16 -18) . Neopterin levels were invariably raised in proven viral hepatitis and higher than in patients with various non-viral, biliary and hepatic disorders. Further, there was a correlation between neopterin levels and other biochemical tests for liver function in viral hepatitis but not in other hepatic diseases.
Patients with chronic persistent non-A, non-B hepatitis and patients with fatty liver rarely show clinical disease and often do not differ in laboratory assays. However, neopterin levels were shown to have significant potential for differential diagnosis of both diseases because neopterin levels are elevated in a high percentage of patients with chronic persistent non-A, non-B hepatitis and usually normal in patients with fatty liver (19) .
From the published data, it can be concluded that neopterin is a highly sensitive indicator for cellular immune responses evoked by viral pathogens. Neopterin can be considered as a potent general marker for viral infections that should enable diagnosis of infections, even with unidentified viruses.
Infections by Human Immunodeficiency Virus (HIV)
In 1983 a pilot study has been conducted on patients with AIDS and with prodromal stages (20) . This result was confirmed and extended later on (21, 22) .
Increased urinary and/or serum neopterin levels were found in about 90% of HIV seropositive parenteral drug addicts (23) , in approximately 85% of seropositive homosexuals (24, 25) , and in 60 -80% of seropositive haemophilic patients (26, 27) . However, in addition to HIV infected individuals also a substantial part of seronegative asymptomatic members of groups with high AIDS incidence showed raised neopterin levels. E. g., 15% of seronegative homosexuals and 50% of seronegative parenteral drug addicts and haemophilic patients had levels above normal range (23, 24, 26) . The magnitude of neopterin levels was correlated with behavioural factors of risk group members: with the number of partners with receptive anal intercourse in homosexuals (28) and with the parenteral mode of drug administration in drug addicts (29) . The presence of at least transient immune stimulation was also shown in recipients of blood transfusions (30) .
These data have shown that the activation of cellmediated immunity represents a prominent cofactor for increased susceptibility for seroconversion and progressive disease following exposure to HIV (29--31) .
Neopterin levels follow closely the course of HIV infection. Moreover, in one patient with fresh HIV infection who attended a clinic due to acute disease, neopterin levels increased 2 weeks before antibodies against HIV became detectable (32). Progressive infection is paralleled by further rising neopterin levels (21, 24, 33) . Whereas there exists no difference of neopterin levels between asymptomatic HIV seropositives and those with persistent generalized lymphadenopathy the correlation with the Walter Reed Staging classification was found to be highly significant (24) . Neopterin levels and CD4 + jCD8 + T cell ratios are inversely correlated in ARC and AIDS patients.
Neopterin has predictive potential in HIV infected individuals. HIV seropositive subjects with high neopterin levels developed symptoms earlier than those with lower levels (34) . High neopterin levels precede progression within the Walter Reed Staging classification scheme (35) . AIDS patients with the highest neopterin levels were observed to die earlier than others (36) . Application of neopterin in HIV disease has been reviewed recently (37) .
Infections by intracellular porotozoa
Extremely high urinary neopterin levels were observed in a group of malarial patients from a non-endemic region (38) . Another study showed almost invariably raised serum neopterin levels during acute malarial attacks with a weak correlation between degree of parasitaemia and neopterin levels (39) . Recovery was accompanied by normalizing neopterin levels.
Urinary neopterin levels were also measured III a holoendemic region (40) . In these patients, neopterin levels were raised but were considerably lower than those of patients from non-endemic areas of similar age. A pronounced age dependence was detected among the patients from the holoendemic area, children showing by far the highest levels. The influence of age on neopterin levels probably reflects a switch from cell-mediated immune mechanisms which are more prominent in young children to humoral immune reactions which are thought to be more prevalent in subjects with increasing age if exposure to the pathogen is persistent (40) .
Infections by intracellular bacteria
Urinary neopterin levels were elevated in 84% of patients with pulmonary tuberculosis (41) . There was a correlation between mean neopterin levels and extent as well as activity of disease. Serially determined neopterin levels reflected accurately the clinical activ-5 ity of tuberculosis under treatment. These observations might be of practical value because there is no other simple laboratory test reliably indicating rapid changes of activity in tuberculosis.
Urinary neopterin levels were increased in 75% of patients with leprosy (42) . No difference could be detected in neopterin levels between patients with lepromatous and with tuberculous type of disease.
Infections by extracellular bacteria
Bacterial infections are not commonly linked with high neopterin levels (13) . However, in 7 of 10 patients with staphylococcal pneumonia raised neopterin levels were observed (43) .
Neopterin levels were studied in intensive care unit patients with and without septic complications (44, 45) . Neopterin was able to differentiate between septic patients and non-septic patients who showed significantly lower neopterin levels. Highly significant differences of neopterin levels were observed between survivors and non-survivors. From these observations, it was concluded that neopterin might be useful to predict clinical course of septic patients.
Autoimmune Disease
Rheumatoid arthritis
As shown in a pilot study (46) and in more extended investigations (47, 48) neopterin levels are significantly linked with stage as well as with clinical activity of rheumatoid arthritis. Significantly higher neopterin levels were found even in patients with rheumatoid arthritis stage I when compared with patients suffering from degenerative non-inflammatory osteoarthrosis. Neopterin levels were weakly correlated with erythrocyte sedimentation rate, haemoglobin levels, white blood cell counts and presence or absence of C-reactive protein and rheumatoid factors (48) . Multivariate analysis showed that the levels of urinary neopterin, C-reactive protein and erythrocyte sedimentation rate were the best combined predictors of clinical activity. The contribution of neopterin to this combination was dominant by statistical criteria.
It was shown recently (49) that neopterin levels 10 synovial fluids from inflammatory joints are significantly raised compared with those from non-inflammatory joints. Furthermore, neopterin levels in synovial fluids were higher than those in serum which appears to indicate local production of neopterin within the inflamed joints.
Ulcerative colitis
The value of urinary neopterin as a marker for clinical activity of ulcerative colitis was compared with that of currently used clinical and laboratory variables (SO). The (descending) order of correlation with clinical activity of disease was: extent of bowel involvement, neopterin levels, erythrocyte sedimentation rate, number of motions per day and, finally, body temperature. Tn another study (51), a significant correlation was found between neopterin levels and T cells bearing the T9 antigen which is an activation marker (51).
Crohn's disease
Urinary neopterin levels were measured in patients with Crohn's disease (52) . Multiple stepwise regression analysis revealed that neopterin was significantly correlated with clinical activity, with duration of disease (inverse correlation) and with index of body weight but not with 12 other clinical and laboratory variables.
For assessment of the clinical course of Crohn 's disease, among other indices the Crohn's Disease Activity Index (CDAI) including 8 variables is often applied at present. A simple triple-parametric index combining haematocrit, urinary neopterin levels and frequency of Iiq uid or very soft stools was constructed on the basis of multiple regression analyses (53) . The results obtained with this index were well comparable to those obtained with the much more complicated CDAI.
A further study revealed a significant association of neopterin levels with clinical activity, with CDAI and , importantly, with the number of activated T cells showing the T9 antigen (51).
Autoimmune thyroiditis
Neopterin levels were examined in patients with different thyroid diseases (54) . Neopterin levels were frequently elevated in patients with autoimmune thyrotoxicosis and with autoimmune hypothyroidism but not in patients with disseminated autonomy and with goiter. Neopterin levels normalized during treatment of hyperthyroid patients when thyroid hormones normalized but remained elevated when the course of disease did not change.
From these results, it was suggested that neopterin might be helpful to differentiate autoimmune from nonautoimmune thyroid diseases and in the management of autoimmune thyrotoxicosis. 
Diabetes mellitus type I
It was proposed that neopterin determination would be useful in monitoring of patients with type I diabetes mellitus. A pilot study showed that urinary neopterin levels were significantly increased in newly diagnosed patients with early onset of type I diabetes and with long lasting diabetes with anti-cytoplasmic islet cell antibodies (55) .
Other Inflammatory Diseases
Sarcoidosis
Urinary neopterin levels were measured concomitantly with clinical status and 67Ga scans in patients with biopsy proven pulmonary sarcoidosis (56) . Neopterin levels were significantly raised in patients with active disease showing higher levels than those with less active disease. Patients with extended alveolar Iympholysis had higher neopterin levels than those with low alveolar lympholysis. A significant correlation between urinary neopterin levels and results of 67Ga scans was also observed.
The observations of these studies were confirmed by further reports in urine as well as in serum (57 -59) .
Coeliac disease
Urinary neopterin levels were measured in children with coeliac disease (60, 61) . There was a highly significant difference between children with active disease and patients without clinical symptoms or patients on gluten-free diet as well as a close correlation between neopterin levels and concomitantly determined titers of anti-gliadin antibodies in serum . Application of gluten-free diet in patients who initially showed active disease, had a marked effect on urinary neopterin levels: Within few days, levels decreased rapidly, indicating the clinical improvement.
Multiple sclerosis and aseptic meningo-encephalifis
Raised levels of neopterin were found in cerebrospinal fluid (CSF) of a majority of patients with multiple sclerosis during exacerbation when compared with periods of remission (62) . High neopterin levels in CSF were not accompanied by neopterin elevation in serum of the patients .
Neopterin levels were also elevated in CSF of most patients with aseptic meningo-encephalitis during the acute phase (63) . They were strongly correlated to the number of mononuclear cells in CSF during course of disease and normalized during recovery.
In general, neopterin levels of controls and of patients with non-inflammatory neurological diseases were lower than those of patients with aseptic meningoencephalitis.
Malignant Diseases
Haematological neoplasias
Raised urinary and/or serum neopterin levels were described in high percentages of patients with active haematological neoplasias by several authors (15, 64 -69) . A pronounced influence of stage on neopterin levels was observed in patients with chronic myelocytic leukaemia, with non-Hodgkin's lymphoma and with multiple myeloma (64) . In the latter disease, a significant correlation between urinary neopterin levels and total estimated mass of tumour cells was found (15) . In general, the majority of patients with haematological neoplasias in remission had neopterin levels within the normal range.
Gynaecological tumours
The percentages of patients with elevated neopterin levels depended on tumour type and tumour stage in women with carcinomas of the genital tract (70, 71) . Patients with benign gynaecological tumours and women with precancerous lesions showed neopterin levels below the upper normal limits. High pretherapeutic neopterin levels were significantly predictive for more unfavourable course of disease and earlier death in cervical cancer (72) as well as in ovarian cancer (73) . Multivariate statistical analysis revealed that haemoglobin, leukocyte number and neopterin were independent significant predictors of survival time in cervical cancer even when adjusted for tumour stage (72) . In ovarian cancer, neopterin was the only significant prognostic variable among a variety of routinely performed laboratory tests (73) . A significant association of neopterin levels measured serially during follow-up with risk of subsequent death, recurrence or metastasis was shown in cervical cancer and in ovarian cancer. Significantly elevated neopterin levels were found already 7 months before death (72, 73) . There was a significant association between the results of serial neopterin levels and histological diagnosis of patients with ovarian carcinoma at second look laparotomy (73) . This observations might be of particular value because a substantial part of patients commonly refuses second look surgery. Furthermore, patients with evidence of disease at second look and with normal neopterin levels were found to have better outcome than women with evidence of tumour and with elevated neopterin levels (73).
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Tumours of the genitourinary tract
Urinary neopterin levels of patients with bladder tumour, with carcinoma of prostate and with testical tumour show a stringent correlation with tumour stage (74, 75) . During follow-up for 4 years, there was a correlation between urinary neopterin levels and clinical condition in patients with seminomatous as well as with non-seminomatous testicular tumours (76) .
Predictive significance of serum neopterin levels was shown in patients with prostatic carcinoma: Patients with elevated neopterin had a significantly worse survival expectation than those with normal neopterin levels (77).
Lung cancer
There was an overall frequency of raised urinary neopterin levels in 58% of patients with lung cancer (78) . A significant difference of neopterin levels between limited and extended disease in small cell carcinoma was observed. 70% of patients with tumour recurrence had elevated neopterin levels. Multivariate survival time analysis (79) did not reveal a significant difference in survival expectation between patients with normal and with elevated neopterin levels in squamous cell carcinoma but in adenocarcinoma and in small cell lung cancer patients the difference was significant.
Gastrointestinal and pancreatic carcinoma
Urinary neopterin levels were elevated in about 50% of patients with gastric carcinoma and with carcinoma of colon or of rectum and in about 70% of patients with pancreatic carcinoma and with biliary tract carcinoma (80) . A recent study (81) confirmed the observed low frequency of neopterin elevations in colorectal carcinomas.
Malignant diseases with low frequencies of elevated neopterin levels
Certain tumour types show elevated neopterin levels in percentages below 25 % : melanomas (69), breast tumours (82, 83) and head and neck cancers (82, 84) .
Application for Screening of Blood Donors
On the basis of an earlier report (22) and due to the large spectrum of diseases indicated by raised neopterin levels with a high sensitivity, neopterin testing of blood donations has become mandatory in the Austrian Tyrol since November 1986. Neopterin levels were determined in 76587 voluntary blood donations during a 21-months period (85) . Raised neopterin levels were found in 1242 (1.6%) of donors. A follow-up investigation could be performed in 650 of these donors. In 148 (22.8%) of the latter, hazardous diseases were detected the knowledge of which at donation would have led to exclusion of the donation in accordance with the official Transfusion Guidelines.
Thus, the application of neopterin for routine screening of blood donors reduces the hazard of transmission of diseases including AIDS via blood transfusion.
Conclusions
Due to its specific production by monocytesjmacrophages stimulated with interferon-gamma raised neopterin is a sensitive indicator for the activation of the cell-mediated immune system in vitro as well as in vivo. Numerous clinical studies which were conducted by a number of research groups in several countries have shown that high neopterin levels are observed in clinical settings recognized or supposed to involve activated cell-mediated immunity. Levels of this pterin are easily measurable by radioimmunoassay in serum or by HPLC in serum and urine. Neopterin carries independent and unique information on the afferent arm of the cellular immune system.
Introduction
The most well-defined biological role of tetrahydropterins in mammals is their function as electron donors in the monooxygenase reactions catalyzed by the three aromatic amino acid hydroxylases, i. e. phenylalanine, tyrosine and tryptophan hydroxylase (for reviews, see refs. 1 -3). These enzymes show a high degree of * Author to whom correspondence should be addressed Enzymes: Tyrosine 3-monooxygenase, tyrosine hydroxylase (EC 1.14.16.2); Phenylalanine 4-monooxygenase, phenylalanine hydroxylase (EC 1.14.16.1). Abbreviations: BH 4 , 6(R)-tetrahydrobiopterin; 4a-OH-BH4, 4a-hydroxy-tetrahydrobiopterin; qBH 2 , quinonoid dihydrobiopterin; 7,8-BH 2 , 7,8-dihydrobiopterin; 6-MPH 4 , 6-methyltetrahydropterin; q6-MPH 2 , quinonoid 6-methyldihydropterin; DOPA, 3,4-dihydroxy-phenylalanine; DTT, dithiothreitol ; EPR, electron paramagnetic resonance; HPLC, high-performance liquid chromatography.
Pteridines / Vo1. 1 . 1989 ~o" Copyright (0 1989 \\"alt er de Gruytcr " Berlin " ~ew York sequence homology and are postulated to have similar reaction mechanisms (1 -4). During catalytic turnover, tetrahydropterins are oxidized to dihydropterins in the tyrosine hydroxylase reaction (1 -3, 5 ), e. g.
The formed dihydrobiopterins (qBH2 and 7,8-BH2) can in turn be regenerated to tetrahydrobiopterin (BH4) by dihydropteridine reductase and dihydrofolate reductase, respectively (2) . Although the overall stoichiometry of the hydroxylation reaction (equation 1) is known , the precise function of the tetrahydrop-terins in the catalytic cycle is still unclear. In addition to their function as electron donors in the reduction of dioxygen, tetrahydropterins may also activate the enzyme, as observed for phenylalanine hydroxylase, in which the catalytically inactive Fe(III) bound to the enzyme appears to be reduced by the cofactor 2,5,6).
Like phenylalanine hydroxylase, bovine adrenal tyrosine hydroxylase also contains substantial amounts of high-spin Fe(III) (7, 8) . However, in contrast to phenylalanine hydroxylase, recent studies on this enzyme (8) have revealed that tetrahydropterins reduce only a minor fraction of the Fe(III) present in the. enzyme as isolated. Since a phosphorylated form of tyrosine hydroxylase has a more favorable Km-value for its cofactor, and possibly also an increased V maxvalue (1, 9), we have now further examined the reactions of the phosphorylated enzyme with the cofactor and the substrate.
Materials and Methods
Tyrosine hydroxylase was purified from the cytosolic fraction of bovine adrenal medulla homogenates, using a new large-scale procedure (8) . Analyses of the phosphate content of various enzyme samples, prepared by this procedure, have shown the presence of somewhat varying amounts of phosphate, i. e. from below 0.2 to approx. 0.6 mol phosphate per mol monomer (8) . The enzyme preparations used in the present study had specific activities of about 400 nmol/(min . mg) when assayed at pH 6.0, using 1 mmol/L 6-methyitetrahydropterin as the cofactor and 0.3 mmol/ L L-tyrosine as the substrate (10).
Incubation Separation
Tyrosine/ Phenylalanine hydroxylases
In the experiments using phosphorylated hydroxylase, . the enzyme (1.5 gi L) was incubated with 0.1 gi L of the catalytic subunit of bovine heart cyclic AMPdependent protein kinase (11) Under these conditions, 0.6 -0.8 mol phosphate per mol enzyme monomer was found to be incorporated into tyrosine hydroxylase (12) . Thus, after phosphorylation, the enzyme contained at least 0.8 mol phosphate per mol monomer. In control experiments, the enzyme was incubated (without added ATP) and gel filtered under identical conditions. Phenylalanine hydroxylase was purified from bovine liver by a slight modification (13) of the procedure of Shiman et al. (14) . (15) . The enzyme was activated by incubation with 2 mmol/L L-phenylalanine at 25 D C for 2 min before the reaction was started by addition of cofactor. After a reaction time of 2 min at 25 D C , a 20 ilL aliquot of the mixture was injected into the liquid chromatograph and the peak corresponding to the 4a-OH-BH 4 was collected at -80°C (Fig. 1) decay of the 4a-hydroxy-tetra hydropterins, carefully controlled incubation time and temperature was necessary in order to obtain reproducible results.
6(R)-BH4 and 6(RS)-methyltetrahydropterin (6-
HPLC analysis of pterins was performed on a Hewlett-Packard 60 x 4.6 mm i. d. (3 !lm particle size) CI S reversed phase column, equipped with a 30 x 4.6 mm i. d. C I8 precolumn (5 !lm particle size) (15) . The degassed mobile phase (ammonium acetate, ammonium formate, potassium phosphate or Tris-HCI) was pumped at 2.0 mL/min. The eluant was monitored with a Hewlett-Packard model 1040A diode array HPLC detector (Fig. 1 ).
X-band EPR spectra at 9.24 GHz microwave frequency were obtained with a Bruker ESP 300 EPR system equipped with an Oxford Instruments helium flow cryostat (ESR-9). The spectra of tyrosine hydroxylase ( 
Results
Kinetics of conversion of 4a-hydroxy-tetrahydropterins to dihydropterins
The 4a-hydroxy-tetrahydropterin has recently been isolated and established as an immediate reaction product of both the phenylalanine and tyrosine hydroxylase reactions with both the naturally occurring and synthetic tetrahydropterins (2, 5, 15, 16) . The formation of the 4a-hydroxy-tetrahydropterins by tyrosine hydroxylase (or phenylalanine hydroxylase) can be selectively measured using high-speed HPLC with UV-detection (15) . The 4a-hydroxy-tetrahydropterins are, however, rapidly dehydrated to the quinonoid dihydropterins in a spontaneous (2, 16, 17) or enzyme catalyzed (2, 17) reaction (equation 2).
Using preparative high-speed HPLC, the enzymatically generated 4a-OH-BH 4 was isolated and stored at -80°C (15) . Its spontaneous decay to qBH2 (equation 2) and the subsequent tautomerization to 7,8-BH2 (equation 3) was followed selectively (Fig. 2A) . The pseudo first-order rate constant (k2 in equation 2) of the non-enzymatic dehydration of the 4a-OH-BH4 in Tris-HCl, pH 7.5, was found to be slightly dependent on the ionic strength. Thus, the observed tl /2 at 23°C was approx . 
The effect of cyclic AMP-dependent phosphorylation of tyrosine hydroxylase on the formation of 4a-O H-BH4
The phosphorylation oftyrosine hydroxylase by cyclic AMP-dependent and other protein kinases is known to stimulate its catalytic activity (for a review, see ref.
1). These studies have all been based on the assay of DOPA as the product of the tyrosine hydroxylase reaction. Using assay conditions which favour the accumulation of 4a-hydroxy-tetrahydropterins (15 -18) , a close correlation has been observed between the amount of 4a-hydroxy-tetrahydropterins recovered by HPLC and the amount of tyrosine formed (15) . From Figure 3 it is seen that the 4a-OH-BH4 formation by tyrosine hydroxylase phosphorylated by the purified catalytic subunit of bovine cyclic AMPdependent protein kinase, is increased about five-fold compared to the non-phosphorylated control enzyme. Under these conditions a similar increased formation of tyrosine from phenylalanine was also observed (data not shown). spectrum of the resting enzyme (Fig. 4b) , the spectrum in the presence of either substrate or cofactor and DTT is markedly changed by phosphorylation . Thus, after incubation with 1.5 mmol/L L-tyrosine (Fig.  4a) , the signal intensity of the species with gmax around 7.0 was significantly reduced. A new high-spin Fe(III) species with a gmax-value of 9.2 appeared, and the contribution around g = 4.3 was considerably increased. In comparison, incubation of the phosphorylated enzyme with 1.7 mmol/L D-tyrosine resulted in an EPR spectrum (Fig. 4c) which was similar to that of the phosphorylated enzyme control (Fig. 4b ). Aerobic incubation with 2 mmol/L 6-MPH 4 and 10 mmol/L DTT makes the previously EPR detectable Fe(III) with gmax ~ 7.0 of the phosphorylated enzyme EPR silent, presumably due to reduction of its ferric iron to Fe(II) (12) . This reduction is slightly influenced by the presence of D-tyrosine (Fig. 4d) . In comparison, if the non-phosphorylated enzyme is incubated with 2 mmol/L 6-MPH 4 and 10 mmol/L DTT, more than 75% of the gmax ~ 7.0 species is still present (data not shown).
Discussion
High-speed liquid chromatography as an analy tical tool in the analysis of unstable lelrahydropterins
During catalytic turnover, both phenylalanine and tyrosine hydroxylase oxidize the tetrahydropterin cofactors, like tetrahydrobiopterin, tetrahydroneopterin and 6-methyl-tetrahydropterin, to their respective 4a-hydroxy-tetrahydropterins (equation 1) (15). These compounds have previously been observed spectroscopically as transient intermediates (2, 15 -18) or analyzed at subzero temperatures (2, 19) . Thus, stopped-flow spectroscopy has provided valuable information about the kinetics and spectral properties of such intermediates formed in the phenylalanine and tyrosine hydroxylase reactions (15, 18) . In order to obtain additional spectral and kinetic information about the oxidation of the cofactor in these reactions, we have developed a HPLC method for the spectroscopic characterization, quantitation and isolation of the unstable pterins formed in the enzymatic reactions (15) . Thus, the HPLC analysis of pteridines (20, 21) has been extended to include also short-lived pterins.
In the present study, this technique has been used to examine the spontaneous dehydration of 4a-OH-BH4. The rate of dehydration of 4a-hydroxy-tetrahydropterins (k2 in equation 2) has been estimated spectroscopically for the synthetic BH4 analogue 6-MPH 4 in a complex reaction mixture (2, 17) . For the biopterin derivative, however, the rate of tautomerization of the quinonoid intermediate dihydropterin (k3 in equation 3) is about 10 times faster, and this reaction therefore interferes in the estimation of the rate constant for the dehydration of 4a-OH-BH4 (k 2 in equation 2) under similar experimental conditions (16, 17) . Using the rapid HPLC method, which separates the different pterins, the two sequential reactions can be studied separately (Fig. 2) . The rate of disappearence of 4a-OH-BH 4 (k2 in equation 2) was found to be only moderately influenced by the nature and concentration of the buffers employed. This is in contrast to the observed effects of buffer ions on the rate of tautomerization of the quinonoid dihydropterins (k3 in equation 3) (22) .
The role of iron in the ty rosine hy droxy lase reaction
Although iron seems to be essential for the catalytic activity of tyrosine hydroxylase, the mechanistic role of the enzyme-bound iron is not understood. The Fe(II) state seems to be catalytically important, since the enzyme is inhibited by low concentrations of Fe(U) chela tors (8) . This is analogous to phenylalanine hydroxylase and rat pheochromocytoma tyrosine hydro·xylase, in which Fe(II) is postulated to be the only active iron species (2, 15, 16) . However, a considerable amount of the iron in tyrosine hydroxylase exists as Fe(III) (8) , which has been studied by various spectroscopic techniques (7, 8, 23) . Thus, tyrosine hydroxylase as isolated has a blue-green colour (7, 8) , and its resonance Raman spectra have been assigned to a coordination of the feedback inhibitors adrenaline and noradrenaline to the enzyme-bound highspin Fe(IU) (23, 24) . In analogy with studies on model complexes, evidence has been obtained in support of a catecholamine coordination which may lower the redox potential of the iron and thus stabilize the Fe(III) state (12, 23, 24) .
After phosphorylation, the Fe(lIJ) species with gmax ~ 7.0 is made EPR-silent by incubation with 6-MPH 4 and DTT (in the absence of added substrate), indicating that · this Fe(III) species is reduced to Fe(II). The phosphorylation oftyrosine hydroxylase does not seem to change the reaction stoichiometry (equation 1), since a comparably increased formation of both 4a-OH-BH4 and tyrosine was observed and no new reaction products were detected. Similarly, the phosphorylated enzyme reacts in a strictly stereospecific manner with tyrosine, i. e. only the L-enantiomer (Fig.  4a) , as previously observed for the catalytic reaction (1, 15) .
While tyrosine hydroxylase as isolated has many spectroscopic features which are distinct from those of phenylalanine hydroxylase, the phosphorylated enzyme shows some similarities to the non-phosphoryl-ated form of phenylalanine hydroxylase. For this enzyme, the direct formation of quinonoid dihydropterin is accompanied by the reduction of its Fe(IIJ), in an activating reaction, which can be inhibited by catecholamines (2, 5, 6) . The molecular events responsible for the activation of tyrosine hydroxylase by phosphorylation (25) is presently not know. Our working hypothesis is that it decreases the affinity of the feedback inhibitors to the Fe(III) (Andersson , K. K . unpublished observations), thus facilitating changes in redox-state of the enzyme-bound iron (12, 24) .
